(18)F-Fluorodeoxyglucose PET/MR Imaging in Head and Neck Cancer.
(18)F-fluorodeoxyglucose (FDG) PET/MR imaging does not offer significant additional information in initial staging of squamous cell carcinoma of the head and neck when compared with standalone MR imaging. In patients with suspected tumor recurrence, FDG PET/MR imaging has higher sensitivity than MR imaging, although its accuracy is equivalent to the accuracy of FDG PET/CT.
Department of Radiology, Dresden University Hospital, Fetscherstr. 74, Dresden 01307, Germany. Electronic address: ivan.platzek@uniklinikum-dresden.de.
Ivan
I
Platzek
D019788:Fluorodeoxyglucose F18; D006257:Head / Q000000981:diagnostic imaging; D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D064847:Multimodal Imaging / Q000379:methods*; D009333:Neck / Q000000981:diagnostic imaging; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
FDG; Head and neck cancer; PET/MRI; Recurrence; Staging